SHE:002603 Market Cap

SHE:002603 has a market cap or net worth of 28.44 billion as of April 28, 2026. Its market cap has increased by 18.61% in one year.

Market Cap

28.44B

Enterprise Value

26.02B

Revenue

6.01B

Ranking

n/a

PE Ratio

n/a

Stock Price

16.99

Market Cap Chart

Since July 28, 2011, SHE:002603's market cap has increased from 18.99B to 28.44B, an increase of 49.75%. That is a compound annual growth rate of 2.77%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	28.00B	-1.82%
Dec 31, 2025	28.52B	6.62%
Dec 31, 2024	26.75B	-30.60%
Dec 29, 2023	38.54B	-23.00%
Dec 30, 2022	50.05B	52.86%
Dec 31, 2021	32.75B	7.84%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Tianjin Pharmaceutical Da Ren Tang Group Corporation	27.05B
Livzon Pharmaceutical Group	26.70B
Dizal (Jiangsu) Pharmaceutical	25.86B
Humanwell Healthcare (Group)	30.36B
Hubei Jumpcan Pharmaceutical	24.61B
Kangmei Pharmaceutical	23.79B
Zhejiang Huahai Pharmaceutical	23.52B
Chengdu Kanghong Pharmaceutical Group	23.31B

Market Cap Rankings